Evidence map›Paper›PMID 27006646›Full record

ArticleJournal of biomolecular techniques : JBT2016

Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens.

Nicholas P Ambulos, Lisa M Schumaker, Trevor J Mathias, Ruth White, Jennifer Troyer, David Wells, Kevin J Cullen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomolecular techniques : JBT, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nicholas P Ambulos1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Lisa M Schumaker1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Trevor J Mathias1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Ruth White1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Jennifer Troyer1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
David Wells1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Kevin J Cullen1 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA; and 2 Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterFrederick National Laboratory for Cancer Research · USUniversity of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
NCI NIH HHS P30 CA134274
6 · The paper itself

Abstract

Available clinical human papilloma virus (HPV) diagnostics for head and neck cancer have limited sensitivity and/or fail to define the HPV genotype. Common HPV genotyping assays are costly and labor intensive. We sought to develop a next-generation sequencing (NGS)-based HPV genotyping assay that was sensitive enough to work on formalin-fixed paraffin-embedded (FFPE) samples. We developed an ion torrent NGS HPV genotyping assay using barcoded HPV PCR broad-spectrum general primers 5(+)/6(+) (BSGP)5(+)/6(+). To validate genotype specificity and use in archived clinical FFPE tumor samples, we compared NGS HPV genotyping at 2 sequencing centers with typing by Roche Linear Array assay in 42 oropharyngeal and cervical cancer specimens representing 10 HPV genotypes, as well as HPV-negative cases. To demonstrate the detection of a broad range of HPV genotypes, we genotyped a cohort of 266 cervical cancers. A comparison of NGS genotyping of FFPE cancer specimens with genotyping by Linear Array showed concordant results in 34/37 samples (92%) at sequencing site 1 and 39/42 samples (93%) at sequencing site 2. Concordance between sites was 92%. Designed for use with 10 ng genomic DNA, the assay detected HPV using as little as 1.25 ng FFPE-derived genomic DNA. In 266 cervical cancer specimens, the NGS assay identified 20 different HPV genotypes, including all 13 carcinogenic genotypes. This novel NGS assay provides a sensitive and specific high-throughput method to detect and genotype HPV in a range of clinical specimens derived from FFPE with low per-sample cost.

Indexed as

DNA, ViralFemaleFormaldehydeGenotyping TechniquesHigh-Throughput Nucleotide SequencingHuman papillomavirus 16HumansOropharyngeal NeoplasmsParaffin EmbeddingSensitivity and SpecificitySequence Analysis, DNATissue FixationUterine Cervical NeoplasmsDNA, ViralFormaldehydehead and neck cancerhuman papillomavirusviral

Identifiers

PMID27006646
PMCPMC4802743
OpenAlexW2318175102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.